Skip to content

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Serum Antimullerian Hormone Levels in Patients Who Underwent Uterine Artery Ligation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03896243
Enrollment
102
Registered
2019-03-29
Start date
2018-01-01
Completion date
2019-02-01
Last updated
2019-03-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Reserve, Uterine Artery Ligation

Keywords

Uterine atony, amh

Brief summary

Investigators would like to see the amh values after uterine artery ligation

Detailed description

Group/cohort: Uterine artery ligation (UAL) Investigators would like to invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. Participants would be evaluated for their ovarian reserve via hormones and antral follicle count (AFC) Control Group: Investigators would like to invite the patients to the hospital at least 6 months after C-section who delivered baby without any complication. Participants would be also evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Interventions

DIAGNOSTIC_TESTUterine artery ligation (UAL)

Uterine artery ligation (UAL) We will invite the patients to the hospital at least 6 months after surgery who underwent only uterine artery ligation performed due to uterine atony during C-section. They will evaluated for their ovarian reserve via hormones and antral follicle count (AFC)

Sponsors

Kanuni Sultan Suleyman Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* age 18- 35 years * no systemic or endocrine diseases * patients who had uterine artery ligation due to atony * healthy postpartum patients as controls

Exclusion criteria

* patients with PCOS * Pregnancy with IVF or oosit donation * Patients with endocrinopathy, diseases which require radiotherapy and chemotherapy etc. * Patients with BMI \>40

Design outcomes

Primary

MeasureTime frameDescription
1.ovarian reserve in patients with uterine artery ligation12 monthscalculation of ovarian reserve with amh (ng/ml) after uterine artery ligation due to uterine atony

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026